Effects of (-)epigallocatechin gallate and thymoquinone on proliferation of a PANC-1 cell line in culture

Biomedical Sciences Instrumentation

Volumn 42, Issue , 2006, Pages 363-371

  Tan, Mary ^a   Norwood, Anne ^a   May, Merilyn ^a   Tucci, Michelle ^a   Benghuzzi, Hamed ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Complementary medicine; Epigallocatechin; PANC 1; Pancreatic cancer; Thymoquinone

Indexed keywords

ANTIOXIDANTS; BIOCHEMISTRY; DATABASE SYSTEMS; DRUG DOSAGE; MORPHOLOGY; ONCOLOGY; TUMORS; CELL PROLIFERATION; INSTRUMENTS; LANDFORMS;

COMPLEMENTARY MEDICINE; EPIGALLOCATECHIN; PANC-1; PANCREATIC CANCER; THYMOQUINONE;

CELL CULTURE;

ANTIOXIDANT; EPIGALLOCATECHIN GALLATE; THYMOQUINONE;

ALTERNATIVE MEDICINE; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; PANCREAS CANCER; PANCREAS CARCINOMA; TEA;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BENZOQUINONES; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PANCREATIC NEOPLASMS; TREATMENT OUTCOME;

COMPLEMENTARY MEDICINE; EPIGALLOCATECHIN; PANC- 1; PANCREATIC CANCER; THYMOQUINONE;

EID: 70449107828     PISSN: 00678856     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (53)

1. Gold, E.B. and S.B. Gold, Epidemiology of and risk factors for pancreatic cancer. Surgical Oncology Clinicians North America, 1998(7): p. 67-91.
2. Di Magno, E.P., H.A. Reber, and M.A. Tempero, AGA technical review on the epidemiology, diagnosis and treatment of pancreatic ductal adenocarcinoma. Gastroenterology, 1999(117): p. 1464-84.
3. Niederhuber, J.E., M.F. Brennan, and H.R. Menck, The National Cancer Data Base report on pancreatic cancer. Cancer, 1995(76): p. 1671-7.
4. Parker, S., T. Tong, and S. Bolden, Cancer statistics. CA Journal of Clinical Cancer, 1997(47): p. 5-27.
5. Frei, B. and J.V. Higdon, Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr, 2003, 133(10): p. 3275S-84S.
6. Bushman, J.L., Green tea and cancer in humans: a review of the literature. Nutr Cancer, 1998, 31(3): p. 151-9.
7. Balasubramanian, S. and R.L. Eckert, Green teapolyphenol and curcumin inversely regulate human involucrin promoter activity via opposing effects on CCAAT/enhancer-binding protein function. J Biol Chem, 2004. 279(23): p. 24007-14.
8. Baltaziak, M., et al., Green tea as an antioxidant which protects against alcohol induced injury in rats -a histopathological examination. Folia Morphol (Warsz), 2004, 63(1): p. 123-6.
9. Chandra, S. and E. De Mejia Gonzalez, Polyphenolic compounds, antioxidant capacity, and quinone reductase activity of an aqueous extract of Ardisia compressa in comparison to mate (Ilex paraguariensis) and green (Camellia sinensis) teas. J Agric Food Chem, 2004, 52(11): p. 3583-9.
10. Chen, J.H., et al., Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am J Clin Nutr, 2004. 80(3): p. 742-51.
11. Kitani, K., T. Yokozawa, and T. Osawa, Interventions in aging and age-associated pathologies by means of nutritional approaches. Ann N Y Acad Sci, 2004. 1019: p. 424-6.
12. Ahmad, N., et al., Green tea constituent epogallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. Journal National Cancer Institute, 1997(89): p. 1881-1886.
13. Chen, Z., et al., Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Letters, 1998(129): p. 173-179.
14. Ji, B.T., et al., Green tea consumption and the risk of pancreatic and colorectal cancers. Division of Epidemiology, Columbia University, School of Public Health, 1997.
15. Hiura, A. and M. Tsutsumi, Inhibitory effect of green tea extract on the process of pancreatic carcinogenesis induced by N-nitorsobis-(2-oxypropyl)amine and on tumor promotion after transplantation of N-nitorsobis-(2-hydroxypropyl) amine (BHP)-induced pancreatic cancer in Syrian hamsters. Pancreas, 1997(15): p. 272-7.
16. Takada, M., et al., Inhibitory effect of epigallocatechin-3-gallate on growth and invasion in human biliary tract carcinoma cells. World Journal Surgery, 2002, 26(6): p. 683-6.
17. Wu, A., et al., Green tea and risk of breast cancer in Asian Americans. International Journal Cancer, 2003, 106(4): p. 574-9.
18. Pianetti, S., et al., Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Research, 2002, 62(3): p. 652-5.
19. Sartippour, M., et al., Inhibition of fibroblast growth factors by green tea. International Journal Oncology, 2002, 21(3): p. 487-91.
20. Vergote, D., et al., (-)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts. Breast Cancer Research, 2002(76): p. 195-201.
21. Haskim, I.A., et al., Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. Journal Nutrition, 2003. Oct;133(10): p. 3303S-3309S.
22. Zhong, L., et al., A population based case control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology, 2001, 12(6): p. 695-700.
23. Jian, L., et al., Protective effect of green tea against prostate cancer: a case-controlled study in southeast China. International Journal Cancer, 2003.108(1): p. 130-5.
24. Gupta, S., N. Ahmad, and H. Mukhtar, Prostate cancer chemoprevention by green tea. Seminars Urologic Oncology, 1999(17): p. 70-76.
25. Li, N., C. Han, and J. Chen, Effects of tea on DMBA-induced oral carcinogenesis in hamsters. 1999, Institute of Nutrition and Food Hygiene: Beijing. p. 289-92.
26. Liu, J., et al., Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and decarbazine in mice. Journal Cellular Biochemistry, 2001, 83(4): p. 631-42.
27. Lu, Y., et al., Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat. Cancer Research, 2001, 61(13): p. 5002-9.
28. Jung, Y., M. Kim, and B. Shin, EGCG, a major component of green tea, inhibits tumor growth by inhibiting VEGF induction in human colon carcinoma cells. British Journal Cancer, 2001(84): p. 844-850.
29. Takada, M., et al., Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas, 2002, 25(1): p. 45-8.
30. Gali-Muhtasib, H., et al., Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via ap53-dependent mechanism. Int J Oncol, 2004, 25(4): p. 857-66.
31. Corder, C., et al., Delayedapoptosis upon the treatment of Hep-2 cells with black seed. Biomed Sci Instrum, 2003, 39: p. 365-70.
32. Hansen, J.T., et al., The role of black seed in the proliferation and biochemical marker levels of Hep-2 cells. Biomed Sci Instrum, 2003, 39: p. 371-6.
33. Kirui, P.K., et al., Effects of sustained delivery of thymoqiunone on bone healing of male rats. Biomed Sci Instrum, 2004, 40: p. 111-6.
34. Chakravarty, N., Inhibition of histamine release from mast cells by nigellone. Ann Allergy, 1993, 70(3): p. 237-42.
35. Mahgoub, A.A., Thymoquinone protects against experimental colitis in rats. Toxicol Lett, 2003. 143(2): p. 133-43.
36. Hajhashemi, V., A. Ghannadi, and H. Jafarabadi, Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug. Phytother Res, 2004, 18(3): p. 195-9.
37. Shoieb, A.M., et al., In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Int J Oncol, 2003, 22(1): p. 107-13.
38. Worthen, D.R., O.A. Ghosheh, and P.A. Crooks, The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L. Anticancer Res, 1998, 18(3A): p. 1527-32.
39. Badary, O.A., et al., The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats. Toxicology, 2000, 143(3): p. 219-26.
40. El-Mahmoudy, A., et al., Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages. Int Immunopharmacol, 2002, 2(11): p. 1603-11.
41. El-Dakhakhny, M., et al., Nigella sativa oil, nigellone and derived thymoquinone inhibit synthesis of 5-lipoxygenase products in polymorphonuclear leukocytes from rats. J Ethnopharmacol, 2002, 81(2): p. 161-4.
42. Burits, M. and F. Bucar, Antioxidant activity of Nigella sativa essential oil. Phytother Res, 2000, 14(5): p. 323-8.
43. Hanson, J., et al., The role of lack seed in the proliferation and biochemical marker levels of HEP-2 cells. Biomedical Environmental Science, 2003, 39: p. 371-376.
44. Richards, L.R., et al., The synergistic effect of conventional and sustained delivery of antioxidants on LNCaP prostate cancer cell line. Biomed Sci Instrum, 2003, 39: p. 402-7.
45. Ohishi, T., et al., Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane. Cancer Lett, 2002, 177(1): p. 49-56.
46. Suganuma, M., et al., Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res, 1999, 59(1): p. 44-7.
47. Greenberg, D., The vitamin fraud in cancer quackery. Western Journal Medicine, 1975(122): p. 345-348.
48. Labriola, D. and R. Livingston, Possible interactions between dietary antioxidants and chemotherapy. Oncology, 1999(13): p. 1003-1012.
49. El-Abhar, H.S., D.M. Abdallah, and S. Saleh, Gastroprotective activity of Nigella saliva oil and its constituent, thymoquinone, against gastric mucosal injury induced by ischaemia/reperfusion in rats. J Ethnopharmacol, 2003, 84(2-3): p. 251-8.
50. Lyn-Cook, B.D., et al., Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer, 1999. 35(1): p. 80-6.
51. Ahn, W.S., et al., Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev, 2003, 12(5): p. 383-90.
52. Araki, R., et al., Chemoprevention of mammary preneoplasia. In vitro effects of a green tea polyphenol. Ann N Y Acad Sci, 1995, 768: p. 215-22.
53. Ohata, M., et al., Effects of tea constituents on cell cycle progression of human leukemia U937 cells. Biomedical Research, 2005. 26(1): p. 1-7.